Fbln2 is a member of the fibronectin family of proteins that was identified as a key factor in pathological remodeling after myocardial infarction, and complete deletion of Fbln2 significantly improves survival, reduces the incidence of pericardial rupture and attenuates progressive left ventricular dysfunction [23,24]. Here, FBLN2 is linked to myocardial infarction.